SSKN — STRATA Skin Sciences, Inc.
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1051514 ·
Last close
$0.14
Market Cap
$853.8K
52W High
$0.31
52W Low
$0.11
ADV30
12,017
Next earnings
2026-05-26
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 9,292,000 | 5,614,000 | -647,000 | 58,000 | 30,521,000 | 7,912,000 | 27,613,000 |
| Sep 2025 | 6,929,000 | 4,184,000 | -1,173,000 | -1,622,000 | 30,717,000 | 7,076,000 | 29,403,000 |
| Jun 2025 | 7,663,000 | 4,306,000 | -2,224,000 | -2,489,000 | 30,722,000 | 5,966,000 | 30,414,000 |
| Mar 2025 | 6,812,000 | 3,647,000 | -2,015,000 | -2,432,000 | 34,262,000 | 6,512,000 | 31,593,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,794,000
Investing CF
$-1,468,000
Financing CF
$3,579,000
CapEx
$-2,033,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.05
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-254,405,000
Inventory
$2,814,000
Receivables
$4,121,000
ST Investments
—
EBIT TTM
$-4,514,000
Pretax Income TTM
$-6,473,000
Interest Exp TTM
$1,959,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$30,696,000
EBITDA
$-1,712,000
Free Cash Flow
$-1,333,250
Enterprise Value
$9,243,646
Total Cash
$7,912,000
Total Debt
$16,268,000
Shares Out
5,888,199
Trailing EPS
$-1.35
Book Value
$0.49
ROE
-158.9%
ROA
-11.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 30,696,000 | -5,835,000 | -6,261,000 | 30,521,000 | 27,613,000 | — | -2,794,000 |
| Dec 2024 | 33,562,000 | -4,987,000 | -10,086,000 | 34,928,000 | 29,956,000 | — | 188,000 |
| Dec 2023 | 33,358,000 | -6,320,000 | -10,830,000 | 42,016,000 | 29,328,000 | — | -519,000 |
| Dec 2022 | 36,161,000 | -4,649,000 | -5,549,000 | 52,272,000 | 30,441,000 | — | -924,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$30,410,000
NetIncome TTM
$-3,708,000
OpCashFlow TTM
$0
Assets (Latest)
$46,778,000
Forward EPS
$-1.29
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NUMD | Nu-Med Plus, Inc. | $852.2K | $0.01 | — |
| ODYY | Odyssey Health, Inc. | $1.18M | $0.01 | — |
| LGMK | LogicMark, Inc. | $512.9K | $0.57 | — |
| YBGJ | Yubo International Biotech Ltd | $1.43M | $0.01 | — |
| ESMC | ESCALON MEDICAL CORP | $1.56M | $0.21 | — |
News headlines (Yahoo Finance, 1h cache)
New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA’s Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
2026-05-18 12:30 · Yahoo
STRATA Skin Sciences Confirms Nasdaq Delisting
2026-02-19 21:05 · Yahoo
SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy
2026-02-18 14:51 · Yahoo
Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser
2026-02-18 13:15 · Yahoo
STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis
2026-02-17 13:15 · Yahoo
Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences
2026-02-11 13:00 · Yahoo
STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico
2025-12-09 13:15 · Yahoo
Strata Skin Sciences Inc (SSKN) Q3 2025 Earnings Call Highlights: Navigating Challenges and ...
2025-11-17 03:00 · Yahoo
STRATA Skin (SSKN) Earnings Call Transcript
2025-11-13 22:42 · Yahoo
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
2025-11-13 21:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.